Importantly, a positive correlation between BAP1 and MCRS1/DID01 expression has been identified in ccRCC tissues, and downregulation of MCRS1/DID01 in BAP1-deficient tumors has been associated with adverse clinicopathological features113,114. Here, BAP1 is linked to nonpapillary renal cell carcinoma.